![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pictor Awarded CE-IVD Mark for Its COVID-19 Antibody Assay
Pictor Awarded CE-IVD Mark for Its COVID-19 Antibody Assay
Pictor has received CE-IVD mark certification for its PictArray SARS-CoV-2 immunoglobulin G antibody test.
The assay detects if a patient has antibodies from a previous infection by the SARS-CoV-2 virus, based on viral spike protein and nucleocapsid protein antibodies, or from vaccination. It also indicates whether at-risk patients have failed to mount a detectable antibody response despite vaccination or infection.
Due to its ability to differentiate between natural and vaccine-based antibodies, the PictArray test could help in future vaccine development, the company said.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct